Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-11-16 RECTOR DAVID Director Grant or award · Common Stock Options +59,090 1,383,989
2012-11-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Options +252,000 1,302,563
2012-11-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Options +124,242 1,426,805
2012-08-08 FORBES CHRISTOPHER Director Conversion +4,292,583 $0.26 $1.1M 12,754,818
2012-08-08 FORBES CHRISTOPHER Director Conversion · Series B Convertible Preferred Stock −1,000 0
2012-08-08 Waksal Harlan Director Conversion +858,517 $0.26 $223K 2,805,750
2012-08-08 Waksal Harlan Director Conversion · Series B Convertible Preferred Stock −200 0
2012-05-16 QUICK THOMAS C Director Grant or award · Common Stock Option +34,146 841,185
2012-05-16 Van Hulst Jack Director Grant or award · Common Stock Option +31,708 967,917
2012-05-16 Waksal Harlan Director Grant or award · Common Stock Option +46,342 1,702,330
2012-05-16 BRACA JOHN N Director Grant or award · Common Stock Option +10,976 1,053,591
2012-05-16 STALDER RUEDI Director Grant or award · Common Stock Option +40,244 1,472,657
2012-05-16 RECTOR DAVID Director Grant or award · Common Stock Option +10,976 1,030,899
2012-05-16 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +35,366 1,050,563
2012-03-29 Browne Leslie J President and CEO Purchase +10,000 $0.26 $3K 19,000
2012-03-22 Klaver Paul Edward 10% owner Gift −3,000,000 7,146,527
2012-03-22 Klaver Paul Edward 10% owner Gift +3,000,000 10,146,527
2012-03-15 Klaver Paul Edward 10% owner Gift −2,000,000 8,146,527
2012-03-15 Klaver Paul Edward 10% owner Gift +2,000,000 10,146,527
2012-02-16 BRACA JOHN N Director Grant or award · Common Stock Option +15,626 1,042,615

Page 24 of 26 · 511 trades